Close

Russia to present Sputnik V vaccine against coronavirus at United Nations

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

AI-Driven Pharmacovigilance with Real-Time Data Monitoring

Pharmacovigilance is about looking out for bad stuff from...

Russia’s permanent mission to the UN and the Health Ministry will hold a presentation, which will provide detailed information on the Russian vaccine against the novel coronavirus disease (COVID-19), mission spokesman Fyodor Strzhizhovsky told Sputnik.

During a speech at the UN General Assembly in September, Russian President Vladimir Putin suggested that the organisation’s employees be provided with the Russian vaccine against coronavirus free of charge. Russia’s Permanent Representative to the UN Vassily Nebenzia, in turn, did not rule out that the vaccine developers would present it at the UN headquarters.

“On Wednesday, December 2, a presentation of the Russian Sputnik V vaccine will take place. Russian Health Minister Mikhail Murashko, Russia’s Permanent Representative to the UN Vassily Nebenzia, and head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriyev will take part in the event,” Strzhizhovsky said.

He said a virtual event entitled “Sputnik V: Vaccine Against COVID-19” will be held on the sidelines of a special session of the UN General Assembly. During the meeting, detailed information on the Russian vaccine will be presented.

In August, Russia’s Health Ministry registered the world’s first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Centre. It was named Sputnik V. The vaccine is based on a well-studied and validated human adenoviral vector platform, the important benefits of which are safety, efficacy and no long-term adverse effects.

>>>

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories